Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
Clinical trial NCT05532059 · RECRUITING
Trial details
- NCT number
- NCT05532059
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-31
- Primary completion
- 2025-08-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.